Penetrex

Quick links to important sections

Penetrex

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Penetrex

Property Description
Active ingredient Enoxacin (often as sesquihydrate)
Form Film-coated tablet
Pharmacological class Fluoroquinolone Antibiotic
Common use Systemic bacterial infection
Origin Synthetic organic compound

What is Penetrex and What Type of Medicine is It?

Penetrex is the former trade name for a pharmaceutical product whose active ingredient is enoxacin (IUPAC Name: 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid). This medication is classified as a synthetic antibacterial agent belonging specifically to the fluoroquinolone family of antibiotics. The drug is recognized as a second-generation fluoroquinolone, a class generally reserved for the treatment of moderate to severe infections that require a potent, systemic solution. Its classification confirms its role as a powerful, prescription-only agent used in combating established microbial threats, demonstrating broad-spectrum action against both Gram-positive and Gram-negative bacteria.

Composition and Physical Form of the Drug

The formulation centers on enoxacin as the sole active ingredient, presented as a single-active ingredient product intended primarily for adult patient groups. The active compound is a synthetic organic compound, which is typically stabilized as enoxacin sesquihydrate for use in medicine. The medication is commonly manufactured as a film-coated tablet for oral administration, allowing the agent to be absorbed and distributed systemically.

General Purpose: How Penetrex Targets Infection

The general purpose of Penetrex is to effectively eliminate microbial threats through its bactericidal action, a function recognized as resulting in rapid bacterial cell death. Enoxacin achieves this by acting as an inhibitor of essential bacterial enzymes, specifically DNA gyrase and topoisomerase IV. These two enzymes are vital for the bacteria's survival, as they are responsible for the replication, repair, and untangling of its genetic material. By disrupting these processes, the drug prevents the microorganisms from multiplying and thereby helps the body resolve the underlying infectious disease.

What side effects are possible with Penetrex?

Possible Side Effects and Safety Information

The safety profile for Penetrex (enoxacin) is classified by regulatory agencies based on frequency and the organ system affected. The most common adverse reactions officially documented generally involve the Gastrointestinal System, such as nausea, diarrhea, and abdominal pain. Effects on the Nervous System are also common, including headache, dizziness, and insomnia.


Serious and Disabling Adverse Reactions

Official labeling for enoxacin highlights the risk of disabling and potentially irreversible side effects affecting the Musculoskeletal and Nervous Systems.

System Affected Serious Reaction Examples
Musculoskeletal Tendinitis and Tendon Rupture (may occur months after stopping treatment), joint and muscle pain.
Nervous System Peripheral Neuropathy (symptoms like tingling or numbness in the limbs), seizures, confusion, and psychiatric effects.
Cardiac Disorders Aortic aneurysm/dissection and heart valve regurgitation (class effects)

These serious adverse events may appear within hours to weeks after starting treatment. Furthermore, official safety constraints note a potential for photosensitivity (increased skin sensitivity to sunlight).


Population-Specific Safety Notes

The risk of tendon injury is specifically elevated in certain groups, including older adults, patients with renal impairment, and individuals receiving systemic corticosteroids. Safety information advises that fluoroquinolones should generally be reserved for certain infections when alternative treatment options are not available.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information for Penetrex (enoxacin) strictly defines the manifestations of overdose and the required emergency actions.

Documented Overdose Manifestations

Regulatory documentation indicates that the most significant and common manifestation of an enoxacin overdose is the occurrence of seizures or convulsions. These severe neurological events underscore the urgent need for medical intervention. Gastrointestinal disturbances are also documented signs of overdose, which may include indigestion, nausea, vomiting, and abdominal pain.

Regulator-Mandated Emergency Actions

If an overdose of Penetrex is suspected, official guidance mandates that the patient seek immediate medical attention. Immediate contact with a Poison Control Center is also required as a critical first step. The risk of severe central nervous system effects, specifically seizures, is the primary factor necessitating this urgent response.

Supportive Management

The regulatory label does not specify the existence of a known antidote for enoxacin overdose. Therefore, management of an overdose is restricted to symptomatic and supportive treatment to address the patient's clinical state, as determined by qualified medical professionals. There are no population-specific overdose considerations explicitly stated in the available official labeling.

Therapeutic Uses of Penetrex

The fluoroquinolone antibiotic Penetrex (enoxacin) is commonly used to help with the management of bacterial infections and provides supportive relief for associated symptoms in adult patients. It is relevant in contexts involving heightened systemic burden, contributing to easing the overall symptom load in conditions characterized by periods of heightened symptoms. The therapeutic domains of this medication include infections of the genitourinary tract (such as UTIs and prostatitis) and uncomplicated gonorrhea.


Easing Symptom Burden and Supporting Functional Stability

Penetrex is considered relevant in clinical settings marked by the heightened distress of lower respiratory tract infections, such as bacterial bronchitis, where it is applied to ease challenging symptoms like fever, chills, and a significant productive cough. It helps address symptom clusters that may become intense or disruptive, often associated with conditions presenting with systemic or localized discomfort.

“The medication is used across domains where short-term, potent antibacterial assistance is appropriate.”

It is used in situations involving certain distressing symptoms to address clusters like dysuria (painful urination) and pelvic discomfort, which may assist with maintaining functional stability and supports patients during episodes of heightened discomfort during the acute phase. This targeted management helps maintain a sense of stability when symptoms become more noticeable.


Quick Fact: Support for Urinary Distress


Eligibility and Restrictions for Use

Penetrex (enoxacin) eligibility is defined by regulatory authorities and is primarily established for the adult patient population. The medicine is subject to several strict contraindications and population-specific restrictions, reflecting the known risks of the fluoroquinolone antibiotic class.


Contraindicated Populations

Use of Penetrex is absolutely prohibited in specific groups, as stated in regulatory labeling:

  • Individuals with a known history of hypersensitivity to enoxacin or any other quinolone antibiotic.
  • Patients with a prior history of tendinitis or tendon rupture related to the use of any fluoroquinolone.
  • Individuals diagnosed with epilepsy or a personal history of convulsive attacks.

Restricted and Not Recommended Use

Use is not recommended for children and growing adolescents due to the risk of arthropathy. It is also generally not recommended during pregnancy (FDA Category C) or lactation.

Special caution is required for older adults and patients with renal impairment, certain Central Nervous System disorders, or cardiac risk factors. Restrictions also apply to patients concurrently receiving corticosteroid drugs or who have received a solid organ transplant.

What should I know about interactions with other medicines?

Penetrex Interactions with other medicines and products

Penetrex (enoxacin) has documented interactions with several categories of medicinal products, primarily due to two distinct mechanisms: reduced oral absorption and altered metabolism of co-administered drugs.

Significant Drug Interactions and Restrictions

Mechanism / Interaction Type Interacting Products / Categories
Reduced Oral Bioavailability Antacids (aluminum, magnesium, calcium), Sucralfate, Mineral Supplements (iron, zinc), Bismuth Subsalicylate, and Didanosine (chewable/buffered).
Altered Metabolism (CYP450 inhibition) Methylxanthines (e.g., theophylline, caffeine), Warfarin, Digoxin

Enoxacin is a potent inhibitor of the hepatic cytochrome P-450 enzyme system, which significantly decreases the clearance of methylxanthines like theophylline, leading to elevated and potentially toxic serum concentrations. Close monitoring and possible dosage adjustment of theophylline are required.

Preparations containing polyvalent cations (e.g., aluminum, calcium, iron, magnesium, zinc) can substantially reduce the oral absorption of enoxacin through chelation, which may lead to treatment failure. To mitigate this effect, these cation-containing products must not be taken within 8 hours before or 2 hours after enoxacin administration. Caution is also advised when co-administering with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), as this combination may increase the risk of CNS excitation and seizures.

Mechanism of Action

Targeting Bacterial Genetic Integrity

The primary action of Enoxacin is to bind to and inhibit two critical microbial enzymes: DNA Gyrase and Topoisomerase IV. This targeted binding is the molecular event that initiates the drug’s cascade, specifically acting on the genetic pathways involved in bacterial DNA management and replication.

Initiating the Bactericidal Cascade

The inhibition is achieved by trapping the enzymes after they have cleaved the bacterial DNA, thereby preventing the crucial resealing step. This mechanism leads to the rapid accumulation of irreparable double-strand DNA breaks, which is a lethal form of chromosomal damage that completely arrests fundamental cellular processes like replication and transcription.

Limitations Due to Target Specificity

The final physiological consequence, microbial cell death, is constrained by biological resistance mechanisms. This includes target mutations that reduce the drug's binding affinity to the enzymes, and the action of bacterial efflux pumps that actively prevent the drug from reaching effective concentrations at the genetic target site.

Dosage and Administration Information

The use of Penetrex (enoxacin) is governed by specific, non-instructional guidelines outlined in prescribing information. The medicine is manufactured as 200 mg and 400 mg film-coated tablets and is approved exclusively for oral administration.


Administration Schedule and Dosage

The general dosing pattern requires the medicine to be taken every 12 hours (twice daily) for the full specified duration of treatment. The duration is condition-specific, ranging from 7 days for uncomplicated urinary tract infections up to 14 to 30 days for prostatitis. An exception is the regimen for uncomplicated gonorrhea, which is administered as a single 400 mg dose.


Contextual Use and Fluid Requirements

Proper administration is strictly constrained by the timing relative to food and certain supplements. The tablet must be taken on an empty stomach, specifically at least one hour before or two hours after a meal. To prevent potential interference with absorption, doses must be separated from products containing multivalent cations (e.g., antacids with aluminum or magnesium, iron or zinc supplements) by a minimum of eight hours before or two hours after taking the enoxacin tablet. Furthermore, the guidelines include the requirement for drinking plenty of extra fluids daily while on the medication.


Population-Specific Dosing Rules

For patients with compromised renal function (Creatinine Clearance le 30 mL/min), the standardized protocol requires a dose modification. The maintenance dose must be reduced to one-half the recommended dose taken every 12 hours, following the administration of a normal initial dose.

Recent Clinical Evidence

Research Evidence and Studies for Penetrex (Enoxacin)

This overview provides a factual summary of the types of research conducted on Penetrex (enoxacin), detailing what researchers have explored and the structural limitations that exist, without offering medical advice or making claims about expected outcomes.


Evidence for Use in Urinary Tract Infections (UTIs)

Research exploring how symptoms change over time in UTIs has included comparative clinical trials, where enoxacin was studied against other antibiotics, as well as noncomparative studies and scientific reviews. These studies monitored key outcomes related to systemic patterns, including changes in bacterial counts and outcomes describing episodic or acute changes in patient-reported signs (Clinical Resolution) in adult populations.

What remains uncertain is how enoxacin was studied against other therapeutic agents used in current clinical practice, with the evidence base being primarily composed of older trials. There is limited information for long-term outcomes, and follow-up durations were limited, which contributes to the limited characterization of the maintenance of findings over time.


Evidence for Use in Uncomplicated Gonorrhea

Studies exploring uncomplicated gonorrhea involved comparative and noncomparative clinical trials. Research focusing on conditions involving acute or disruptive episodes was conducted on adult patients using short-course, single-dose administration protocols. The research examined patient-reported outcomes describing perceived discomfort by monitoring bacterial counts.

However, follow-up durations were limited, especially regarding the long-term monitoring of antibiotic resistance development, and data are still emerging in this area. The evidence base relies primarily on historical clinical studies, with a low evidence level.


What Remains Uncertain About Penetrex Research

Findings were mixed across the overall evidence landscape, and several research limitation frames apply. The research base is older, and comparative evidence is lacking against many contemporary first-line therapies. Sample sizes were modest in some studies, and follow-up durations were limited, meaning long-term outcomes are not fully established. Additionally, research in special populations such as children or very older adults with multiple comorbid conditions is not widely characterized in the summaries.

Frequently Asked Questions (FAQ)

Common questions about Penetrex (FAQ)


Q: Can Penetrex be used for muscle soreness after exercise?

According to the official product information, Penetrex (enoxacin) is a systemic antibiotic prescribed for specific bacterial infections, including urinary tract infections and gonorrhea. Its regulatory designation is exclusively for combating established microbial threats. It is not approved for conditions like general muscle soreness after exercise.


Q: Can I use Penetrex if I am taking over-the-counter anti-inflammatory medicine?

Regulatory documents describe that caution is advised when this medication is co-administered with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). The combination of these medications is noted to potentially increase the risk of central nervous system (CNS) excitation and seizures. This information is a descriptive constraint and is not personal medical advice.


Q: Can I use Penetrex if I am pregnant or breastfeeding (informational only)?

Official regulatory information indicates that the safety and effectiveness of Penetrex have not been established for women who are pregnant or breastfeeding. For this reason, use is generally not recommended during these periods. The drug is classified as Pregnancy Category C by the FDA, which is a statement about the type of data available.


Q: Can children or teenagers use Penetrex?

According to official prescribing information, use is generally not recommended for children and growing adolescents. This caution is stated because other drugs belonging to the same antibiotic class have been reported to cause arthropathy, or joint damage, in studies involving immature animals.


Q: How long does the effect of Penetrex generally last?

The drug's standardized regimen is to be taken every 12 hours. This is consistent with pharmacological information describing the drug's serum elimination half-life, which is approximately 6 hours in individuals with normal kidney function. This half-life is the time it takes for the concentration of the medicine in the blood to be reduced by half.


Q: Is there a maximum number of times per day that Penetrex is described to be used?

Official regulatory documents describe the standard administration pattern for Penetrex as a regimen that requires administration every 12 hours for the specified duration of treatment. This schedule corresponds to the established guidelines for taking the medication.


Q: Does the application of heat (like a heating pad) affect Penetrex?

Penetrex (enoxacin) is an oral tablet, and official storage guidelines require it to be kept away from excessive heat to maintain its stability. It is important to clarify that some confusion exists because topical products marketed under the same name carry specific warnings about applying local heat sources like heating pads.


Q: Where does Penetrex fit compared to other topical rubs?

Official regulatory information clarifies that Penetrex is the former trade name for a drug whose active ingredient is enoxacin, which is a systemic fluoroquinolone antibiotic. This product is manufactured as an oral tablet for internal use and is pharmacologically distinct from topical rubs.


Q: How does the action of Penetrex compare to deep heat creams?

The drug's mechanism of action is based on its role as an antibiotic, where it inhibits critical bacterial enzymes to eliminate infection. This is fundamentally different from deep heat creams, which typically use chemical counter-irritants to create a physical sensation of heat on the skin.


Q: Are there any common misuses of Penetrex that people should know about?

Official documents contain administration constraints that address potential interference with absorption. These state that the tablet must be separated from products containing polyvalent cations, such as antacids or iron supplements, by a minimum of eight hours before or two hours after taking the dose. Not adhering to this separation has the potential to interfere with the drug’s intended absorption.


Q: Are there reports of skin irritation after using Penetrex?

The official safety profile for the oral tablet lists photosensitivity as a potential adverse reaction, meaning the skin may be more sensitive to sunlight. However, general skin irritation is not among the most common adverse reactions officially documented in regulatory information for this systemic medication.


Q: Is Penetrex safe to use on the face or near the eyes?

Penetrex (enoxacin) is a film-coated tablet approved solely for oral administration and is distributed throughout the body to treat systemic infections. It is not an external product that should be applied topically to the face or near the eyes.


Q: What are the general expectations for when Penetrex starts to work?

Regulatory information describes the drug's potent bactericidal action, which is a mechanism designed to cause rapid bacterial cell death soon after administration. However, official documents do not provide a standard timeline for when an individual patient can expect a symptomatic change.


Q: What does 'non-greasy formula' mean for the absorption of Penetrex?

The product described in official regulatory documents is a film-coated tablet intended to be swallowed for internal use. The term "non-greasy formula" is a descriptor used for topical products that are applied to the skin and is irrelevant to the oral tablet formulation of this medication.


Q: Is Penetrex available in liquid or patch form?

According to official product labeling, the medication is manufactured exclusively as film-coated tablets for oral administration. The regulatory documents do not describe the availability of the drug in liquid or patch forms.


Q: Is the research evidence for Penetrex considered strong or limited?

Regulatory summaries note that the evidence base relies primarily on older trials, and comparative evidence against many contemporary first-line therapies is lacking. Additionally, follow-up durations in the existing studies were limited, meaning long-term outcomes are not fully established.


Q: How does Penetrex differ from standard menthol-based creams?

The oral tablet differs from topical menthol-based creams in several fundamental ways. Its purpose is to treat systemic bacterial infection, its mechanism involves DNA inhibition, and its route is oral administration, which is entirely distinct from the localized, external application of topical creams.


Q: Are there guidelines regarding using Penetrex on large body areas?

Since the medication is a systemic, oral tablet that is swallowed, guidelines regarding its use are focused on dosing schedules and co-administration constraints. Limitations concerning application on large body areas are a constraint relevant to topical medications, not systemic tablets.


Q: Why is the application area limited according to some reports?

The drug (enoxacin) is a systemic, oral tablet that does not have an application area, as it is swallowed and distributed throughout the body. Reports concerning limited application areas are characteristic of topical medicines, leading to potential confusion regarding the correct use of this oral antibiotic.

How should Penetrex be stored and disposed of?

How to Store and Dispose of Penetrex (Enoxacin Tablets)

The storage and disposal of Penetrex must follow the constraints set forth in official regulatory labeling to maintain the product's integrity and ensure safety.


Official Storage Requirements

Item Requirement
Temperature & Environment Store at controlled room temperature, away from excessive heat, moisture, and direct light.
Handling Constraints The product must be kept from freezing and stored in a closed, tightly sealed container.
Child Safety It is mandatory to keep out of the reach of children.

Official Disposal Rules

Disposal Method: The preferred method for discarding unused or expired tablets is an official drug take-back program.

Household Trash: If a take-back program is unavailable, tablets must be mixed with an unappealing substance (like used coffee grounds), sealed in a bag, and placed in the household trash. The product must not be flushed down the toilet or poured down a sink. All personal information on the label must be scratched out before discarding the packaging.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Penetrex found in:

A-Z Index: